Canale-Theakston Carin 4
4 · Cidara Therapeutics, Inc. · Filed Jun 24, 2022
Insider Transaction Report
Form 4
Canale-Theakston Carin
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-22+28,000→ 28,000 totalExercise: $0.53Exp: 2032-06-21→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2023 annual meeting of stockholders.